{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:42:05Z","timestamp":1790379725032,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["29-A-3"],"award-info":[{"award-number":["29-A-3"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2023-J-03"],"award-info":[{"award-number":["2023-J-03"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2020-J-3"],"award-info":[{"award-number":["2020-J-3"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ck0106355"],"award-info":[{"award-number":["JP19ck0106355"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16ck0106138"],"award-info":[{"award-number":["JP16ck0106138"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ck0106618"],"award-info":[{"award-number":["JP21ck0106618"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.esmogo.2025.100178","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:31:00Z","timestamp":1747380660000},"page":"100178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-1419","authenticated-orcid":false,"given":"H.","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-807X","authenticated-orcid":false,"given":"T.","family":"Okusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-707X","authenticated-orcid":false,"given":"N.","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-5298","authenticated-orcid":false,"given":"J.","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmogo.2025.100178_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","article-title":"Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies","volume":"20","author":"Kawasaki","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.esmogo.2025.100178_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamaoncol.2022.3395","article-title":"Effectiveness of etoposide and cisplatin vs irinotecan and cisplatin therapy for patients with advanced neuroendocrine carcinoma of the digestive system: the TOPIC-NEC phase 3 randomized clinical trial","volume":"8","author":"Morizane","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmogo.2025.100178_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lungcan.2014.02.005","article-title":"Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients","volume":"84","author":"Fiegl","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.esmogo.2025.100178_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/JTO.0b013e31819140fb","article-title":"Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity","volume":"4","author":"Ou","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.esmogo.2025.100178_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214599","article-title":"Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer","volume":"14","author":"Shirasawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.esmogo.2025.100178_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100178_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw277","article-title":"Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas","volume":"109","author":"Lamarca","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.esmogo.2025.100178_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/cas.12473","article-title":"Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system","volume":"105","author":"Yamaguchi","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.esmogo.2025.100178_bib9","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1007\/s00432-022-04314-5","article-title":"Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy","volume":"149","author":"Rosery","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.esmogo.2025.100178_bib10","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.3390\/cancers13164232","article-title":"Exploration of novel prognostic markers in grade 3 neuroendocrine neoplasia","volume":"13","author":"Abdelmalak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmogo.2025.100178_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.esmogo.2025.100178_bib12","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.2147\/JIR.S369993","article-title":"Modified Glasgow prognostic score is better for predicting oncological outcome in patients with soft tissue sarcoma, compared to high-sensitivity modified Glasgow prognostic score","volume":"15","author":"Nakamura","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.esmogo.2025.100178_bib13","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/jcm9061677","article-title":"Well differentiated grade 3 neuroendocrine tumors of the digestive tract: a narrative review","volume":"9","author":"Pellat","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.esmogo.2025.100178_bib14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/JCO.2003.06.100","article-title":"Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer","volume":"21","author":"Halabi","year":"2003","journal-title":"J Clinl Oncol"},{"key":"10.1016\/j.esmogo.2025.100178_bib15","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ejca.2009.04.016","article-title":"LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)","volume":"45","author":"Agarwala","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmogo.2025.100178_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2022.09.001","article-title":"Lactate dehydrogenase and its clinical significance in pancreatic and thoracic cancers","volume":"86","author":"Comandatore","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.esmogo.2025.100178_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/CBM-160580","article-title":"Prognostic significance of serum LDH in small cell lung cancer: a systematic review with meta-analysis","volume":"16","author":"Zhang","year":"2016","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.esmogo.2025.100178_bib18","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1111\/1759-7714.13581","article-title":"Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy","volume":"12","author":"He","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.esmogo.2025.100178_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920915299","article-title":"Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis","volume":"12","author":"McNamara","year":"2020","journal-title":"Ther Adv Med Oncol"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:00:04Z","timestamp":1778936404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":19,"alternative-id":["S2949819825000470"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100178","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100178"}}